NCT01598415 - Safety of Single Doses of SAR113945 and Efficacy and Safety of a New Formulation Given Into the Knee in Osteoarthritis Patients / Part II | Biotech Hunter

Enrollment

130

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions

Knee Osteoarthritis

Interventions

DRUG

SAR113945

"Pharmaceutical form:Injection~Route of administration: Intra-articular"

DRUG

placebo

"Pharmaceutical form:Injection~Route of administration: Intra-articular"

Trial Locations (2)

Investigational Site Number 276001, Berlin

Investigational Site Number 276002, München